RecruitingNot ApplicableNCT05776797

AV Junction Ablation or Optimal Medical Treatment in PatiEnts With Cardiac Resynchronization Therapy and Permanent Atrial Fibrillation


Sponsor

University Hospital Ostrava

Enrollment

480 participants

Start Date

Apr 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

A study comparing atrioventricular junction ablation (AVJA) versus continued optimum medical rate control in patients with cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) with suboptimal heart rate control on optimum medication.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This trial is comparing two strategies for people with atrial fibrillation (AFib) and heart failure who have already had a cardiac resynchronization therapy (CRT) device implanted — a device that helps both sides of the heart beat in a coordinated way. The study compares optimal medication management alone versus adding an ablation procedure (using heat to destroy the junction between the upper and lower heart chambers) to force the CRT device to fully control the heartbeat. **You may be eligible if...** - You have had a CRT device (biventricular pacemaker or conduction system pacemaker) for more than 6 months - You have permanent or recurrent persistent atrial fibrillation requiring emergency care or hospitalization - You are on optimized heart failure medications and rate control drugs - You are between 18 and 85 years old **You may NOT be eligible if...** - You do not have atrial fibrillation or heart failure requiring a CRT device - Your ventricular pacing from the CRT device is already nearly 100% - You have severe health conditions that make ablation unsafe Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREAtrioventricular junction ablation in patients with cardiac resynchronization therapy (CRT)

Ablation of the atrioventricular (AV) node is a procedure used to disrupt or break the electrical connection between the upper heart chambers (the atria) and the lower heart chambers (the ventricles).

DRUGOptimal medication treatment in patients with cardiac resynchronization therapy (CRT)

Optimal medication therapy according to the prescription of the physician.


Locations(9)

Regional Hospital Liberec

Liberec, Liberec Region, Czechia

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, Czechia

Hospital Podlesí, Inc.

Třinec, Moravian-Silesian Region, Czechia

University Hospital Olomouc

Olomouc, Olomouc Region, Czechia

Hospital České Budějovice

České Budějovice, South Bohemian Region, Czechia

St. Anne's University Hospital Brno

Brno, South Moravian, Czechia

University Hospital Brno

Brno, South Moravian, Czechia

Institute of Clinical and Experimental Medicine

Prague, Czechia

Military University Hospital Prague

Prague, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05776797


Related Trials